Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

rTEST COVID-19 qPCR SuperRapid Kit

Manufactured by MultiplexDX s.r.o., Slovakia - www.multiplexdx.coom 

Device identification number
3156
CE Marking
Yes
HSC common list (RAT)
×No
Format
Automated, Fully automated (robot), Lab-based, Manual, Semi-automated
Physical Support
Microplate, Strip
Target type
Nucleic acid
Targets
envelope protein/gene, ORF1b polyprotein/gene
Specimen
Other biological fluids, Sputum, Throat secretion
Cross-reactivity (pathogens tested)
Alpha Coronavirus 229E (HCoV-229E), Alpha Coronavirus Nl63 (HCoV-Nl63), Beta Coronavirus HKU1 (HCoV-HKU1), Beta Coronavirus OC43 (HCoV-OC43), Influenza A, Influenza A H1N1, Influenza A H3N2, Influenza A H5N1, Influenza B, MERS-CoV, Parainfluenza Virus Type, Respiratory Syncytial V (RSV), Rhinovirus, SARS-CoV
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Comments
rTEST COVID-19 qPCR SuperRapid kit is a diagnostic kit designed to detect SARS-CoV-2 genomic RNA from samples obtained by gargling without prior RNA extraction. The rTEST COVID-19 qPCR SuperRapid kit is an innovative, improved, and re-designed version of the WHO-recommended Charitè, Berlin protocol. The kit contains three sets of primers and hydrolysis probes (TaqMan®) for multiplex detection of SARS-CoV-2 specific E gene and RdRP gene, together with human RNase P. TaqMan® probes for E gene are conjugated to fluorophore YY, TaqMan® probes for the RdRP gene they are conjugated to the fluorophore FAM and the TaqMan® probe for RNase P is conjugated to the fluorophore Cy5. Such labelling allows for multiplexed detection of SARS-CoV-2 and human RNase P, which serves as an internal control to verify proper sampling and assay performance. To detect the SARS-CoV-2 E gene and the RdRP gene, we have developed patented dual TaqMan® probes, the use of which increases the sensitivity and specificity of our 1-step RT-qPCR. The kit is intended exclusively for use in a diagnostic laboratory with the appropriate equipment, safety standards and properly trained personnel. One package of the kit is sufficient for 400 tests.
Assay Type
Nucleic acid-PCR
Self Test
No
Method
RT-PCR
Time
45 minutes
LOD
1000 cpm
Positive control
RNA isolated from cell cultured SARS-CoV-2
Analytical Sensitivity
100 %
Analytical Specificity
100 %
Clinical Sensitivity
100 %
Clinical Specificity
100 %

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements